How does crossmatching help ensure transfusion safety?

Master the CAMLPR Transfusion Test with interactive questions and detailed explanations. Boost your knowledge and ensure you're exam-ready with comprehensive study resources!

Multiple Choice

How does crossmatching help ensure transfusion safety?

Crossmatching goes beyond simply checking ABO compatibility by testing the recipient’s antibodies against the antigens on the donor’s red cells, and by confirming that the chosen donor unit is compatible with the patient’s antibody profile. In practice, the patient’s serum or plasma is tested against the donor’s red cells; a negative result means the donor cells are compatible with the recipient's antibodies, while a positive result indicates an incompatibility that would risk a transfusion reaction. This process helps detect clinically significant antibodies to non-ABO antigens—such as Kell, Duffy, Kidd, and others—that could cause hemolysis if the wrong donor unit were given. It also ensures that the specific donor unit will be safe for that particular recipient, providing a layer of safety beyond ABO/Rh typing. Infectious risk testing for donors is a separate safety measure, and antibody screening is an initial step to identify antibodies in the recipient’s plasma. Crossmatching adds the final confirmation that the selected donor unit will not react with the patient’s antibodies, making transfusion safer.

Crossmatching goes beyond simply checking ABO compatibility by testing the recipient’s antibodies against the antigens on the donor’s red cells, and by confirming that the chosen donor unit is compatible with the patient’s antibody profile. In practice, the patient’s serum or plasma is tested against the donor’s red cells; a negative result means the donor cells are compatible with the recipient's antibodies, while a positive result indicates an incompatibility that would risk a transfusion reaction. This process helps detect clinically significant antibodies to non-ABO antigens—such as Kell, Duffy, Kidd, and others—that could cause hemolysis if the wrong donor unit were given. It also ensures that the specific donor unit will be safe for that particular recipient, providing a layer of safety beyond ABO/Rh typing.

Infectious risk testing for donors is a separate safety measure, and antibody screening is an initial step to identify antibodies in the recipient’s plasma. Crossmatching adds the final confirmation that the selected donor unit will not react with the patient’s antibodies, making transfusion safer.

More practice questions